title: Overexpression of integrin beta1 inhibits proliferation of hepatocellular carcinoma cell SMMC-7721 through preventing Skp2-dependent degradation of p27 via PI3K pathway.
abstract: Integrins may play important roles in many cellular events, such as cell proliferation, differentiation, and apoptosis. We showed previously that overexpression of integrin beta1 inhibits cell proliferation in SMMC-7721 cells. Here we reported that one of the cyclin-dependent kinase (CDK) inhibitors, p27(Kip1) was involved in proliferation-inhibition induced by overexpression of integrin beta1. Overexpression of integrin beta1 upregulated p27(Kip1) at the protein level, but not mRNA level. The knock-down of p27(Kip1) expression restored cell growth in integrin beta1-overexpressing cells. Cycloheximide (Chx) treatment and pulse-chase experiments revealed that overexpression of integrin beta1 prolonged the half-life of p27(Kip1) by inhibiting its degradation. Proteasome inhibitor (MG132) treatment of the cells indicated that proteasome mediated degradation of p27, and Skp2-dependent degradation might be prevented. Overexpression of integrin beta1 decreased Skp2 at mRNA level, which was regulated by cell adhesion and the subsequent adhesion-dependent signaling. Overexpression of integrin beta1 reduced cell adhesion, accordingly, inactivated the phosphoinositide 3-kinase (PI3K) signaling. PI3K inhibitor LY294002 upregulated p27(Kip1) at post-translational level and downregulate Skp2 at mRNA level, which could mimic the effects of integrin beta1 overexpression on p27(Kip1) and Skp2. Together, these results suggested that overexpression of integrin beta1 inhibited cell proliferation by preventing the Skp2-dependent degradation of p27(Kip1) via PI3K pathway.
authors.affiliation: Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
authors.forename: Yi
authors.initials: Y
authors.lastname: Fu
authors.forename: Zhengyu
authors.initials: Z
authors.lastname: Fang
authors.forename: Yulong
authors.initials: Y
authors.lastname: Liang
authors.forename: Xiaodong
authors.initials: X
authors.lastname: Zhu
authors.forename: Peterbram
authors.initials: P
authors.lastname: Prins
authors.forename: Zengxia
authors.initials: Z
authors.lastname: Li
authors.forename: Liying
authors.initials: L
authors.lastname: Wang
authors.forename: Lidong
authors.initials: L
authors.lastname: Sun
authors.forename: Jiawei
authors.initials: J
authors.lastname: Jin
authors.forename: Yong
authors.initials: Y
authors.lastname: Yang
authors.forename: Xiliang
authors.initials: X
authors.lastname: Zha
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D002448:Cell Adhesion; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000378:metabolism; D005786:Gene Expression Regulation; D006801:Humans; D019012:Integrin beta1 / Q000096:biosynthesis* / Q000378:metabolism; D008113:Liver Neoplasms / Q000378:metabolism*; D008954:Models, Biological; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D061988:Proteasome Inhibitors; D044786:S-Phase Kinase-Associated Proteins / Q000378:metabolism*; D013347:Subcellular Fractions / Q000378:metabolism; D013778:Tetrazolium Salts / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology
chemical_list: D019012:Integrin beta1; D061988:Proteasome Inhibitors; D044786:S-Phase Kinase-Associated Proteins; D013778:Tetrazolium Salts; D013844:Thiazoles; D050760:Cyclin-Dependent Kinase Inhibitor p27; D019869:Phosphatidylinositol 3-Kinases; C022616:thiazolyl blue